- ￥2890
- LSM Bio
- 0.31-20ng/ml
- 0.1ng/ml
- 国产
- ELA-E1259h
- 2025年07月08日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
50
- 供应商：
LSMBIO
- 检测范围：
0.31-20ng/ml
- 检测方法：
夹心法/竞争法
- 应用：
夹心法/竞争法ELISA体外定量检测人血清、血浆或其它相关生物液体中蛋白浓度
- 适应物种：
人
- 标记物：
tumor marker DR- 70 for lung cancer
- 样本：
人血清、血浆或其它相关生物液体中天然和重组蛋白
- 灵敏度：
0.1ng/ml
- 规格：
96T
Human tumor marker DR- 70 for lung cancer ELISA Kit
Product Name:Human tumor marker DR- 70 for lung cancer ELISA Kit
Packing:96T
Catalog No.:ELA-E1259h
Gene Name:DR-70TM
Detect Range:0.312-20 ng/mL
Sensitivity:0.039ng/mL
Target Protein Name:tumor marker DR-70 for lung cancer
Alternative Name:DR-70TM,tumor marker DR-70 for lung cancer
Sample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA Kit
Product Description:Human tumor marker DR- 70 for lung cancer ELISA Kit allows for the in vitro quantitative determination of tumor marker DR-70 for lung cancer concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:
The microtiter plate provided in Human tumor marker DR- 70 for lung cancer ELISA Kit has been pre-coated with an tumor marker DR-70 for lung cancer antibody specific to tumor marker DR-70 for lung cancer .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for tumor marker DR-70 for lung cancer and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain tumor marker DR-70 for lung cancer, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm.The concentration of tumor marker DR-70 for lung cancer in the samples is then determined by comparing the O.D. of the samples to the standard curve.
NOTE:FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ ENTIRE PROCEDURE!
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Lung-Specific Expression of Mutant p53 as Mouse Model for Lung Cancer
The p53 tumor suppressor gene is the most commonly mutated gene in cancer (1 ,2) and is mutated in 50% non-small cell lung cancer (NSCLC) and 70% of small cell lung cancer (SCLC) (3) . Mutations in p53 commonly reflect exposures
Determination of Biological Parameters on Fine-Needle Aspirates from Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for approximately 75% of all human lung carcinomas and is a major cause of mortality worldwide (1 ). About 70% of the cases are diagnosed at an advanced stage, thus being suitable
SPR1: An Early Molecular Marker for Bronchial Carcinogenesis
and regulation of SPR1 is closely linked to multistep carcinogenesis of lung cancer in a series of human bronchial epithelial cell lines representing different stages of malignant transformation (10 ). Early in the transformation of bronchial epithelial cells
技术资料暂无技术资料 索取技术资料
